OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Effect of Forex Changes

Change in reported cash caused by exchange-rate movements on foreign-currency balances.

OrganiGram Holdings Inc.TSX: OGI.TO

Effect of Forex Changes · Q2 FY2026 · quarter ended Mar 2026

Effect of forex changes growth accelerates

Q2 FY2026 effect of forex changes of CA$404K rose 910.0% year over year, ahead of the -195.6% change in trailing-twelve-month effect of forex changes.

Context

  • Effect of forex changes amounted to 0.1% of revenue in FY2025, up 0.1 pp from a year earlier.
  • Effect of forex changes increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +910.0% holds above the trailing-twelve-month pace of -195.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$404K+164.5% QoQ
Last fiscal yearSep 2025
CA$313K— YoY
LTMMar 2026
-CA$1.96M-195.6% YoY
Effect of Forex Changes past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+910.0%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Effect of Forex Changes history

CAD · from the cash flow

Latest · FY2025
313K CAD
Year-over-year change
—

Effect of Forex Changes vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so effect of forex changes is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -195.6% is the lowest of 8, against a peer median of +147.7%.
  • Effect of forex changes amounts to 0.7% of revenue for OGI.TO, versus a peer median of 0.5%.
OGI.TO Competitors
Effect of Forex Changes for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$5.24M CAD-37.5%-56.8%1.7%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$4.33M CAD+1540.2%-34.7%1.4%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$1.96M CAD-195.6%—0.7%
DR.TOMedical Facilities CorporationLTM Mar 2026$1.56M USD+1169.7%+1067.2%0.5%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$415.85K USD+166.5%-12.6%0.8%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$278.55K USD+147.7%-4.5%0.5%
TSND.TOTerrAscend Corp.LTM Mar 2026$199.94K USD-145.3%-10.0%0.1%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$152.59K USD——0.3%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$40.08K USD-96.8%——
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$2K CAD——0.0%
Peer median (excluding OGI.TO) —+147.7%-11.3%0.5%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
Deferred Income Tax42.21M(88K)(3.62M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(5.52M)27.02M13.16M
Other Non-Cash Items776K(29M)155.33M15.09M12.47M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(7.59M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(17.05M)
Acquisitions (Net)(2.54M)(11.06M)1.03M257K(65.62M)
Purchases of Investments(120.02M)(15M)(10M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M49.4M3.52M2.5M
Other Investing Activities(31.08M)4.29M(8.65M)(7.97M)(1.52M)
Investing Cash Flow(115.11M)44.03M1.36M(38.77M)(82.67M)
Debt Repayment(116.4M)(1.01M)(87K)(786K)(60K)
Common Stock Issued284.88M6.34M20K108.56M41.18M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(750K)6K(1.79M)
Financing Cash Flow174.46M5.33M(817K)107.78M39.33M
Effect of Forex Changes0000313K
Net Change in Cash30.77M13.15M(34.65M)72.88M(49.01M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(24.64M)

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.